RETROSPECTIVE STUDY OF SURGICAL TREATMENT OF REFRACTIVE OSTEOMYELITIS AND INFECTIOUS ARTHRITIS IN THE FLIPPERS OF SEALS IN THE NETHERLANDS

2020 ◽  
Vol 51 (3) ◽  
Author(s):  
Anna Salazar-Casals ◽  
Klaas Marck ◽  
Tijmen de Jong ◽  
James Collins ◽  
Joost Dorgelo ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Surgical Treatment ◽  
The Netherlands ◽  
Infectious Arthritis

Surgical treatment of pulmonary metastases from soft tissue sarcomas: A retrospective study in the Netherlands

1994 ◽  
Vol 56 (3) ◽  
pp. 172-177 ◽  
Author(s):  
Albert N. van Ceel ◽  
Frits Van Coevorden ◽  
Jan D. Blankensteijn ◽  
Harald J. Hoekstra ◽  
Bart Schuurman ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Surgical Treatment ◽  
Soft Tissue ◽  
The Netherlands ◽  
Pulmonary Metastases ◽  
Soft Tissue Sarcomas

scholarly journals The prevalence of seasonal affective disorder in the netherlands: a prospective and retrospective study of seasonal mood variation in the general population

1999 ◽  
Vol 45 (8) ◽  
pp. 1013-1022 ◽  
Author(s):  
Peter Paul A Mersch ◽  
Hermine M Middendorp ◽  
Antoinette L Bouhuys ◽  
Domien G.M Beersma ◽  
Rutger H van den Hoofdakker
Keyword(s):  
Retrospective Study ◽  
General Population ◽  
The Netherlands ◽  
Affective Disorder ◽  
Seasonal Affective Disorder ◽  
Mood Variation

scholarly journals The Dose of Somatostatin Analogues during Pre-Surgical Treatment Is a Key Factor to Achieve Surgical Remission in Acromegaly

Endocrines ◽  
2021 ◽  
Vol 2 (3) ◽  
pp. 241-250
Author(s):  
Marta Araujo-Castro ◽  
Eider Pascual-Corrales ◽  
Héctor Pian ◽  
Ignacio Ruz-Caracuel ◽  
Alberto Acitores Cancela ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Surgical Treatment ◽  
Surgical Outcomes ◽  
Pituitary Adenomas ◽  
Somatostatin Analogues ◽  
Beneficial Effects ◽  
Key Factor ◽  
Long Acting ◽  
First Time ◽  
Endocrine Complications

Purpose: to determine whether pre-surgical treatment using long-acting somatostatin analogues (SSAs) may improve surgical outcomes in acromegaly. Methods: retrospective study of 48 patients with acromegaly operated by endoscopic transsphenoidal approach and for first time. Surgical remission was evaluated based on the 2010 criteria. Results: most patients, 83.3% (n = 40), harbored macroadenomas and 31.3% (n = 15) invasive pituitary adenomas. In this case, 14 patients were treated with lanreotide LAR and 6 with octreotide LAR, median monthly doses of 97.5 [range 60–120] and 20 [range 20–30] mg, respectively, for at least 3 months preoperatively. Presurgical variables were comparable between pre-treated and untreated patients (p > 0.05). Surgical remission was more frequent in those pre-treated with monthly doses ≥90 mg of lanreotide or ≥30 mg of octreotide than in untreated or pre-treated with lower doses (OR = 4.64, p = 0.025). However, no differences were found between pre-treated and untreated patients when lower doses were included or between those treated for longer than 6 months compared to those untreated or pre-treated for shorter than 6 months. Similarly, no differences were found either in terms of surgical or endocrine complications (OR = 0.65, p = 0.570), independently of the doses and the duration of SSA treatment (p > 0.05). Conclusions: the dose of SSAs is a key factor during pre-surgical treatment, since the beneficial effects in surgical remission were observed with monthly doses equal or higher than 90 mg of lanreotide and 30 mg of octreotide, but not with lower doses.

scholarly journals Myopia progression from wearing first glasses to adult age: the DREAM Study

2021 ◽  
pp. bjophthalmol-2020-316234
Author(s):  
Jan Roelof Polling ◽  
Caroline Klaver ◽  
Jan Willem Tideman
Keyword(s):  
Retrospective Study ◽  
The Netherlands ◽  
Refractive Error ◽  
High Myopia ◽  
Prognostic Indicator ◽  
Treatment Intensity ◽  
Spherical Equivalent ◽  
Inclusion Criteria ◽  
Myopia Progression ◽  
Adult Age

PurposeData on myopia progression during its entire course are scarce. The aim of this study is to investigate myopia progression in Europeans as a function of age and degree of myopia from first prescription to final refractive error.MethodsThe Drentse Refractive Error and Myopia Study assessed data from a branch of opticians in the Netherlands from 1985 onwards in a retrospective study. First pair of glasses prescribed was defined as a spherical equivalent of refraction (SER) ≤−0.5 D to ≥−3.0 D. Subjects with prescriptions at an interval of at least 1 year were included in the analysis.ResultsA total of 2555 persons (57.3% female) met the inclusion criteria. Those with first prescription before the age of 10 years showed the strongest progression (−0.50 D; IQR: −0.75 to −0.19) and a significantly (p<0.001) more negative median final SER (−4.48 D; IQR: −5.37 to −3.42). All children who developed SER ≤−3 D at 10 years were highly myopic (SER ≤−6D) as adults, children who had SER between −1.5 D and −3 D at 10 years had 46.0% risk of high myopia, and children with SER between −0.5 D and −1.5 D had 32.6% risk of high myopia. Myopia progression diminished with age; all refractive categories stabilised after age 15 years except for SER ≤−5 D who progressed up to −0.25 D annually until age 21 years.ConclusionOur trajectories of the natural course of myopia progression may serve as a guide for myopia management in European children. SER at 10 years is an important prognostic indicator and will help determine treatment intensity.

Sign in / Sign up

Export Citation Format

Share Document